DOP2013000050A - Nuevas proteinas de union a antigenos - Google Patents
Nuevas proteinas de union a antigenosInfo
- Publication number
- DOP2013000050A DOP2013000050A DO2013000050A DO2013000050A DOP2013000050A DO P2013000050 A DOP2013000050 A DO P2013000050A DO 2013000050 A DO2013000050 A DO 2013000050A DO 2013000050 A DO2013000050 A DO 2013000050A DO P2013000050 A DOP2013000050 A DO P2013000050A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- antigen binding
- binding proteins
- cancer
- antigens
- union
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 102000025171 antigen binding proteins Human genes 0.000 abstract 4
- 108091000831 antigen binding proteins Proteins 0.000 abstract 4
- 102100029986 Receptor tyrosine-protein kinase erbB-3 Human genes 0.000 abstract 2
- 101710100969 Receptor tyrosine-protein kinase erbB-3 Proteins 0.000 abstract 2
- 206010005003 Bladder cancer Diseases 0.000 abstract 1
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 206010025654 Malignant melanoma of sites other than skin Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 206010033128 Ovarian cancer Diseases 0.000 abstract 1
- 206010061535 Ovarian neoplasm Diseases 0.000 abstract 1
- 206010060862 Prostate cancer Diseases 0.000 abstract 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 abstract 1
- 208000005718 Stomach Neoplasms Diseases 0.000 abstract 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 206010017758 gastric cancer Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 201000011549 stomach cancer Diseases 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 201000005112 urinary bladder cancer Diseases 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
Abstract
La presente descripción se refiere a proteínas de unión a antígenos, tales como anticuerpos, que se unen a HER3, a polinucleótidos que codifican dichas proteínas de unión a antígenos, a composiciones farmacéuticas que comprenden dichas proteínas de unión a antígenos y a métodos de fabricación. La presente descripción también se refiere al uso de dichas proteínas de unión a antígenos en el tratamiento o profilaxis de enfermedades asociadas con cáncer de mama, cáncer de ovario, cáncer de próstata, cáncer de vejiga, pancreático, gástrico, melanoma y otros cánceres que sobreexpresan HER3.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37684010P | 2010-09-03 | 2010-09-03 | |
| US201161440460P | 2011-02-08 | 2011-02-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DOP2013000050A true DOP2013000050A (es) | 2013-09-15 |
Family
ID=49302177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DO2013000050A DOP2013000050A (es) | 2010-09-03 | 2013-02-26 | Nuevas proteinas de union a antigenos |
Country Status (1)
| Country | Link |
|---|---|
| DO (1) | DOP2013000050A (es) |
-
2013
- 2013-02-26 DO DO2013000050A patent/DOP2013000050A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2013002535A (es) | Nuevas proteinas de union a antigenos. | |
| WO2016059602A3 (en) | Combination therapy with anti-her3 antibodies to treat cancer | |
| MX348637B (es) | Anticuerpos y composiciones anti-her3. | |
| MX2014009289A (es) | Anticuerpos c1orf32 y usos de los mismos para el tratamiento del cancer. | |
| TN2015000396A1 (en) | Antibody drug conjugates | |
| MX2015012122A (es) | Conjugados de anticuerpo-farmaco y los anticuerpos correspondientes. | |
| DOP2013000219A (es) | Anticuerpos imitadores de receptores de celulas t especificos para peptido wt1 unido a hla-a2 | |
| CR20140585A (es) | Proteinas de union a antigeno st2 | |
| TN2014000120A1 (en) | Cd27l antigen binding proteins | |
| NZ606195A (en) | Methods and compositions for liver cancer therapy | |
| AR088171A1 (es) | Anticuerpos anti-erbb3 y usos de los mismos | |
| MX2021002144A (es) | Anticuerpo igf-1r y su uso como un vehiculo con especificidad de objetivo para el tratamiento contra el cancer. | |
| CR20150284A (es) | Terapia de combinación de anticuerpos anti-her3 y anti-her2 | |
| PH12015500751A1 (en) | Anti-her3/her4 antigen binding proteins binding to the beta-hairpin of her3 and beta-hairpin of her4 | |
| PH12015500752A1 (en) | Her3 antigen binding proteins binding to the beta-hairpin of her3 | |
| NZ629553A (en) | Anti-big-endothelin-1 (big-et-1) antibodies and uses thereof | |
| NZ724395A (en) | Anti-pdgf-c antibodies | |
| AR081321A1 (es) | N-cadherina: un blanco para el diagnostico y la terapia del cancer | |
| MX2016005854A (es) | Anticuerpo anti-her3 alosterico de la neuregulina. | |
| DOP2013000050A (es) | Nuevas proteinas de union a antigenos | |
| SA517390221B1 (ar) | Igf-1r الجسم المضاد لـ واستخدامه في تشخيص سرطان | |
| AR082904A1 (es) | Proteinas de union a antigenos | |
| NZ768582A (en) | Antibodies and uses thereof to detect folate receptor 1 |